Roche company profile

Roche is a world leader in the field of international health, a multinational company based on scientific research and development, headquartered in Basel, Switzerland, and one of the top 500 enterprises in the world. Roche was founded in 1896 and 10 for two months. After a hundred years of development, its business has spread all over the world 100 countries, with nearly 66,000 employees. Roche's business scope mainly involves drugs, medical diagnosis, vitamins and fine chemicals, flavors and fragrances and other four fields. Roche is also engaged in research, development and product sales in some important medical fields such as nervous system, virology, epidemiology, oncology, cardiovascular diseases, inflammatory immunity, dermatology, metabolic disorders and orthopedic diseases.

Roche's scientists won the Nobel Prize in Physiology three times. Roche has large scientific research centers in Basel, Switzerland, Natley and Palo Alto in the United States. Among them, Roche's Central Nervous System and Cardiovascular Disease Research Center in Basel and American Gene Research Center enjoy a high reputation in the international medical community.

Roche pharmaceutical production department has a long history, mainly producing various drugs for treating central nervous system diseases, infectious diseases, inflammation, cardiovascular diseases, tumors, viral infections, skin diseases, obesity and so on.

Roche has successfully acquired some major international pharmaceutical companies to strengthen its own strength. These include: acquiring a majority stake in Genentech, the most advanced bioengineering company in the United States, and strengthening Roche's leading position in genetic engineering in the forefront of the pharmaceutical industry; Acquired the over-the-counter department of Nicholas Company and Fei Sen Company, making Roche the largest company in the over-the-counter market in Europe; 1994, the company acquired Cintex Pharmaceutical Company, which doubled Roche's strength in anti-infection and organ transplant drugs. In 20001year, Roche and Japanese and foreign pharmaceutical companies announced the joint establishment of a leading research-oriented Japanese pharmaceutical company, which is a fully functional multinational company headquartered in Japan and ranks fifth in the Japanese market, the second largest pharmaceutical sales market in the world.

Since Roche established the medical diagnosis department from 65438 to 0968, the department has developed at an amazing speed. The reagents produced by this department are widely used in medical immunology tests, such as pregnancy test, hepatitis test and HIV test. From 65438 to 0994, Roche Biomedical Laboratory merged with the National Health Laboratory of the United States to form the largest clinical laboratory organization in the world-American Laboratory Organization, and Roche owns 49.9% of its shares. In medical diagnosis, another outstanding research institution of Roche is Roche Molecular Laboratory. The laboratory is devoted to the research of polymerase chain reaction (PCR), which can replicate the same gene or DNA fragment, and can be widely used in basic research, diagnosis of AIDS, tuberculosis and leukemia, and environmental detection. At the beginning of 1998, Roche completely completed the acquisition of Bolinman Company, absorbed the advantages of this company in products, and became a pioneer in the field of medical diagnosis.

Vitamins and fine chemicals are Roche's third largest business. Roche is the largest manufacturer of vitamin and carotene products in the world, and this position was obtained from the moment when Roche successfully synthesized vitamin C by industrial methods in 1934.